Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations

Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations
Title:
Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations
Other Titles:
Scientific Reports
Keywords:
Publication Date:
15 May 2019
Citation:
Teo, W., Sekar, K., Seshachalam, P. et al. Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient Populations. Sci Rep 9, 7442 (2019). https://doi.org/10.1038/s41598-019-43173-y
Abstract:
Glioblastoma multiforme (GBM), a deadly cancer, is the most lethal and common malignant brain tumor, and the leading cause of death in adult brain tumors. While genomic data continues to rocket, clinical application and translation to patient care are lagging behind. Big data now deposited in the TCGA network offers a window to generate novel clinical hypotheses. We hypothesized that a TCGA-derived gene-classifier can be applied across different gene profiling platforms and population groups. This gene-classifier validated three robust GBM-subtypes across six different platforms, among Caucasian, Korean and Chinese populations: Three Caucasian-predominant TCGA-cohorts (Affymetrix U133A = 548, Agilent Custom-Array = 588, RNA-seq = 168), and three Asian-cohorts (Affymetrix Human Gene 1.0ST-Array = 61, Illumina = 52, Agilent 4 × 44 K = 60). To understand subtype-relevance in patient therapy, we investigated retrospective TCGA patient clinical sets. Subtype-specific patient survival outcome was similarly poor and reflected the net result of a mixture of treatment regimens with/without surgical resection. As a proof-of-concept, in subtype-specific patient-derived orthotopic xenograft (PDOX) mice, Classical-subtype demonstrated no survival difference comparing radiation-therapy versus temozolomide monotherapies. Though preliminary, a PDOX model of Proneural/Neural-subtype demonstrated significantly improved survival with temozolomide compared to radiation-therapy. A larger scale study using this gene-classifier may be useful in clinical outcome prediction and patient selection for trials based on subtyping.
License type:
http://creativecommons.org/licenses/by/4.0/
Funding Info:
This study did not require any funding.
Description:
ISSN:
2045-2322
Files uploaded:

File Size Format Action
s41598-019-43173-y.pdf 2.91 MB PDF Open